Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lyme Carditis in a Transplanted Heart: A Rare Cause of Early Conduction Abnormalities.

JACC. Case reports·2026
Same author

Impact of Life-Context Factors on Chronic Rhinosinusitis 22-Item Sinonasal Outcomes Test: Systematic Review + Meta-Analysis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

CTHRC1: a serum biomarker for a pathological fibroblast in IPF.

Thorax·2026
Same author

Comparative Effectiveness of Single Versus Bilateral Lung Transplantation in Dually Listed Recipients: A National Target Trial.

Annals of surgery·2026
Same author

Development of Mesothelioma in Organ Transplant Recipients: A Comprehensive Study of 10 Cases.

Archives of pathology & laboratory medicine·2026

Related Experiment Video

Updated: Jun 9, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.8K

Prognosis and Risks for Probable Chronic Lung Allograft Dysfunction: A Prospective Multicenter Study.

Jamie L Todd1,2, S Sam Weigt3, Megan L Neely2,4

  • 1Department of Medicine, Duke University Medical Center, Durham, North Carolina.

American Journal of Respiratory and Critical Care Medicine
|October 29, 2024
PubMed
Summary
This summary is machine-generated.

Probable chronic lung allograft dysfunction (CLAD) affects nearly 30% of lung transplant recipients within 3 years, significantly increasing graft loss risk. Early identification of probable CLAD is crucial for timely interventions and improved survival.

Keywords:
acute rejectionchronic lung allograft dysfunctionlung transplantation

More Related Videos

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

20.3K
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

318

Related Experiment Videos

Last Updated: Jun 9, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.8K
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

20.3K
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

318

Area of Science:

  • Pulmonology
  • Transplantation Immunology
  • Clinical Medicine

Background:

  • Chronic lung allograft dysfunction (CLAD) is a primary barrier to long-term lung transplant success.
  • A 2019 consensus defined probable and definite CLAD based on persistent lung function decline, but outcomes for probable CLAD require further investigation.

Purpose of the Study:

  • To prospectively evaluate the prognosis and identify clinical risk factors for probable CLAD in a multicenter lung transplant cohort.
  • To assess the impact of probable CLAD on graft loss and compare its risk factors with definite CLAD.

Main Methods:

  • A prospective multicenter cohort study (Clinical Trials in Organ Transplantation-20) involving 745 lung transplant recipients.
  • Rigorous adjudication of probable CLAD using a 2019 consensus definition.
  • Cox proportional hazards models, including LASSO regularization, were employed to analyze graft loss and identify risk factors for probable CLAD.

Main Results:

  • Probable CLAD developed in 29.7% of patients by 3 years post-transplant, significantly increasing graft loss risk (HR=4.38, P<0.001).
  • 80% of patients with probable CLAD progressed to definite CLAD.
  • Key independent risk factors for probable CLAD included cytomegalovirus infection, late donor-specific antibodies, acute rejection, acute lung injury, and organizing pneumonia.

Conclusions:

  • Probable CLAD serves as an important early indicator of high graft loss risk, supporting its prospective identification for prompt CLAD-directed therapies.
  • Developing strategies to prevent cytomegalovirus infection, manage alloimmunity, and mitigate tissue injury is essential for improving lung transplant recipient survival.